UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2757) 2757
Book Chapter (17) 17
Magazine Article (8) 8
Dissertation (5) 5
Newsletter (4) 4
Newspaper Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2204) 2204
asparaginase - therapeutic use (1409) 1409
science & technology (1304) 1304
male (1278) 1278
female (1247) 1247
life sciences & biomedicine (1234) 1234
child (1082) 1082
asparaginase - administration & dosage (911) 911
adolescent (902) 902
antineoplastic combined chemotherapy protocols - therapeutic use (897) 897
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (857) 857
child, preschool (754) 754
hematology (629) 629
oncology (620) 620
asparaginase - adverse effects (617) 617
adult (606) 606
asparaginase (545) 545
vincristine - administration & dosage (522) 522
biological and medical sciences (486) 486
antineoplastic agents - therapeutic use (483) 483
infant (467) 467
medical sciences (463) 463
leukemia, lymphoid - drug therapy (459) 459
animals (429) 429
chemotherapy (400) 400
middle aged (392) 392
vincristine - therapeutic use (388) 388
methotrexate - administration & dosage (375) 375
remission induction (353) 353
l-asparaginase (352) 352
treatment outcome (339) 339
prednisone - administration & dosage (330) 330
pediatrics (306) 306
leukemia (302) 302
prognosis (297) 297
cytarabine - administration & dosage (289) 289
prednisone - therapeutic use (287) 287
acute lymphoblastic leukemia (275) 275
abridged index medicus (274) 274
leukemia - drug therapy (272) 272
daunorubicin - administration & dosage (270) 270
pharmacology. drug treatments (269) 269
antineoplastic agents (259) 259
cyclophosphamide - administration & dosage (250) 250
cancer (247) 247
daunorubicin - therapeutic use (242) 242
antineoplastic combined chemotherapy protocols - adverse effects (240) 240
aged (234) 234
methotrexate - therapeutic use (233) 233
cytarabine - therapeutic use (230) 230
mice (212) 212
cyclophosphamide - therapeutic use (210) 210
asparaginase - pharmacology (197) 197
antineoplastic agents - adverse effects (195) 195
hematologic and hematopoietic diseases (192) 192
time factors (178) 178
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (177) 177
acute disease (173) 173
precursor cell lymphoblastic leukemia-lymphoma - mortality (173) 173
doxorubicin - administration & dosage (172) 172
disease-free survival (171) 171
leukemia, myeloid, acute - drug therapy (171) 171
mercaptopurine - administration & dosage (169) 169
escherichia coli - enzymology (168) 168
mercaptopurine - therapeutic use (166) 166
enzymes (165) 165
retrospective studies (165) 165
combined modality therapy (162) 162
drug therapy, combination (162) 162
lymphoma, non-hodgkin - drug therapy (158) 158
dexamethasone - administration & dosage (147) 147
recurrence (144) 144
follow-up studies (143) 143
acute lymphocytic leukemia (142) 142
lymphoma - drug therapy (141) 141
prednisolone - administration & dosage (140) 140
young adult (140) 140
risk factors (138) 138
drug administration schedule (136) 136
asparaginase - metabolism (135) 135
remission, spontaneous (135) 135
children (134) 134
antineoplastic agents - administration & dosage (127) 127
acute lymphatic leukemia (126) 126
antineoplastic combined chemotherapy protocols - administration & dosage (126) 126
survival rate (124) 124
care and treatment (120) 120
analysis (118) 118
precursor cell lymphoblastic leukemia-lymphoma - blood (118) 118
asparagine (116) 116
precursor cell lymphoblastic leukemia-lymphoma - pathology (111) 111
vincristine - adverse effects (111) 111
precursor cell lymphoblastic leukemia-lymphoma - complications (110) 110
survival analysis (104) 104
research (103) 103
clinical trials as topic (102) 102
neoplasms - drug therapy (102) 102
age factors (100) 100
prednisolone - therapeutic use (98) 98
lymphatic leukemia (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2347) 2347
German (125) 125
Japanese (75) 75
French (68) 68
Polish (56) 56
Italian (53) 53
Russian (42) 42
Spanish (34) 34
Chinese (28) 28
Portuguese (13) 13
Czech (5) 5
Hungarian (4) 4
Romanian (4) 4
Dutch (3) 3
Norwegian (3) 3
Serbian (3) 3
Swedish (3) 3
Slovak (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 04/2020, Volume 34, Issue 4, pp. 1006 - 1016
Journal Article
British journal of haematology, ISSN 0007-1048, 2008, Volume 141, Issue 6, pp. 840 - 847
Journal Article
Bioconjugate chemistry, ISSN 1043-1802, 03/2018, Volume 29, Issue 3, pp. 649 - 656
Topical Review | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Chemistry, Organic | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Multidisciplinary | Science & Technology | Glucosylceramidase - chemistry | alpha-Galactosidase - therapeutic use | Immunotherapy - methods | Humans | Anti-Inflammatory Agents - immunology | Antineoplastic Agents - therapeutic use | Asparaginase - chemistry | Gaucher Disease - therapy | Enzymes, Immobilized - immunology | Enzyme Therapy - methods | Immunoconjugates - immunology | alpha-Galactosidase - chemistry | Neoplasms - therapy | Lysosomal Storage Diseases - immunology | Anti-Inflammatory Agents - therapeutic use | Immunoconjugates - therapeutic use | Fabry Disease - immunology | alpha-Galactosidase - immunology | Asparaginase - therapeutic use | Enzymes, Immobilized - therapeutic use | Enzymes, Immobilized - chemistry | Biocatalysis | Lysosomal Storage Diseases - therapy | Antineoplastic Agents - immunology | Glucosylceramidase - immunology | Gaucher Disease - immunology | Glycosylation | Inflammation - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Asparaginase - immunology | Inflammation - therapy | Animals | Anti-Inflammatory Agents - chemistry | Glucosylceramidase - therapeutic use | Neoplasms - immunology | Fabry Disease - therapy | Immunohistochemistry | Enzymes | Immunostimulation | Immobilization | Recovery of function | Biocatalysts | Immunity | Substrates | Organic chemistry | Chemical modification | Immunosuppression | Immunotherapy | Catalysis | Half life | Index Medicus
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 12/2008, Volume 22, Issue 12, pp. 2193 - 2200
Journal Article